
Inventiva is a biotechnology business based in the US. Inventiva shares (IVA) are listed on the NASDAQ and all prices are listed in US Dollars. Inventiva employs 109 staff and has a trailing 12-month revenue of around $9.7 million.
How to buy Inventiva stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – IVA. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Inventiva stock price (NASDAQ: IVA)
Use our graph to track the performance of IVA stocks over time.Inventiva shares at a glance
Latest market close | $6.03 |
---|---|
52-week range | $3.49 - $13.66 |
50-day moving average | $4.69 |
200-day moving average | $6.00 |
Wall St. target price | N/A |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.33 |
Buy Inventiva stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Inventiva stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Inventiva price performance over time
Historical closes compared with the close of $6.03 from 2023-01-30
1 week (2023-01-25) | -1.95% |
---|---|
1 month (2022-12-30) | 35.20% |
3 months (2022-11-01) | 29.96% |
6 months (2022-08-01) | 26.15% |
1 year (2022-02-01) | -54.39% |
---|---|
2 years (2021-02-01) | -59.48% |
3 years (2020-01-28) | N/A |
5 years (2018-01-28) | N/A |
Inventiva financials
Revenue TTM | $9.7 million |
---|---|
Gross profit TTM | $7.5 million |
Return on assets TTM | -34.38% |
Return on equity TTM | -70.73% |
Profit margin | 0% |
Book value | $1.66 |
Market capitalisation | $264.6 million |
TTM: trailing 12 months
Inventiva share dividends
We're not expecting Inventiva to pay a dividend over the next 12 months.
Inventiva share price volatility
Over the last 12 months, Inventiva's shares have ranged in value from as little as $3.492 up to $13.66. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inventiva's is 1.0816. This would suggest that Inventiva's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Inventiva overview
Inventiva S. A. , a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis.
Inventiva in the news
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
Results of the votes of the Combined Shareholders’ General Meeting of January 25, 2023
Inventiva To Change Clinical Development of Its Lead NASH Candidate
Frequently asked questions
What percentage of Inventiva is owned by institutions?Currently 23.492% of Inventiva shares are held by institutions. How many people work for Inventiva?
Latest data suggests 109 work at Inventiva. When does the fiscal year end for Inventiva?
Inventiva's fiscal year ends in December. Where is Inventiva based?
Inventiva's address is: 50 rue de Dijon, Daix, France, 21121 What is Inventiva's ISIN number?
Inventiva's international securities identification number is: US46124U1079
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert